Riskpilot← Back to searchSign inGet full accessColdfighter AB
ABBankruptOrg 5569784142Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20141 employees
Revenue 2021
SEK 94K
-55% vs 2020
EBITDA margin
66.0%
-47% vs 2020
Equity ratio
42.3%
Financial strength
Net profit 2021
SEK 49K
-47% vs 2020
| Revenue | SEK 94K | -55% |
| EBITDA | SEK 62K | -47% |
| Net profit | SEK 49K | -47% |
| Total assets | SEK 523K | +0% |
| Equity | SEK 221K | -16% |
| Employees | 1 | — |
Legal name
Coldfighter AB
Org number
5569784142
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
31 juli 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall utveckla,tillverka och sälja hjälpmedel inom hälsa och friskvård och övrig förenlig verksamhet.
Address
Phone
+46730836924
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | 473 | 381 | 284 | 209 | 94 |
| Staff expenses | — | — | — | — | — | — | — |
| EBITDA | 62 | 94 | 40 | 29 | 33 | 117 | 62 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 62 | 94 | 40 | 29 | 33 | 117 | 62 |
| Net financials | — | — | — | — | — | — | — |
| Profit before tax | 62 | 94 | 40 | 28 | 33 | 117 | 62 |
| Tax | −14 | −21 | −9 | −6 | −7 | −25 | −13 |
| Net profit | 48 | 73 | 31 | 22 | 26 | 92 | 49 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Total assets | 353 | 334 | 260 | 224 | 338 | 521 | 523 |
| Equity | 98 | 172 | 202 | 194 | 269 | 263 | 221 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 255 | 162 | 57 | 30 | 68 | 258 | 302 |
| Total debt | 255 | 162 | 57 | 30 | 68 | 258 | 302 |
EBITDA margin
66.0%
This company
15.8%
Market median
+318% vs market
20152021
Equity ratio
42.3%
This company
38.2%
Market median
+11% vs market
20152021
Return on equity
22.2%
This company
18.4%
Market median
+21% vs market
20152021
Net profit margin
52.1%
This company
8.1%
Market median
+543% vs market
20152021
Asset turnover
0.18×
This company
1.12×
Market median
-84% vs market
20152021
Debt / equity
1.37×
This company
0.62×
Market median
-121% vs market
20152021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2014-07-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PE Liquidator | Liquidator | 2024 | — | — |
JD Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Coldfighter AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Erik Bergsten | Liquidator | 0 companies |
| Jim Dan Erik Ottesen | Chief Executive Officer | 0 companies |
| Johanna Martha M Gredfors Ottesen | Deputy Board Member | 0 companies |